Cardiff Oncology (CRDF) Stock Price
$4.75 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
7 -
Technical
8
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Cardiff Oncology, AI stock picks, stock alerts and much more.
CRDF AI Stock Analysis
AI stock analysis for CRDF is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Cardiff Oncology (CRDF) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Cardiff Oncology (CRDF) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Cardiff Oncology (CRDF), currently trading at $4.75, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About CRDF
-
Cardiff Oncology, Inc.
-
Symbol
CRDF
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
316M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
CRDF Alternative Data
Web Traffic
Cardiff Oncology receives an estimated 6738 monthly visitors to cardiffoncology.com.
-
Web Traffic
6738
-
Change from Previous Month
48%
-
3 Month Change
51.4%
-
YoY Change
51.4%
News Mentions
Cardiff Oncology was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Cardiff Oncology has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
0%
Twitter Followers
Cardiff Oncology has 1,056 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.5% over the last month.
-
Twitter Followers
1056
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
0.7%
Facebook Engagement
Cardiff Oncology has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
LinkedIn Followers
4,903 are following Cardiff Oncology on LinkedIn, up by 4.1% over the last month.
-
LinkedIn Followers
4903
-
Daily Change
0.2%
-
1 Month Change
4.1%
-
3 Month Change
7.7%
Job Postings
Cardiff Oncology currenly has an estimated 1 open job postings.
-
Job Postings
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Cardiff Oncology has 55 employees.
-
LinkedIn Employees
55
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
CRDF Financials
CRDF Key Metrics
-
Total Revenue
$165K
-
Net Income
-$11.9M
-
Earnings per Share
-$0.25
-
Free cash flow
-$10.5M
-
EBITDA
-$12.5M
-
EBITDA Ratio
-75.7576
-
Total Assets
$62.9M
CRDF 2-year Revenue & Income
CRDF 2-year Free Cash Flow
CRDF Technicals
CRDF SMA
CRDF RSI
FAQ
What's the current price of Cardiff Oncology (CRDF) Stock?
The price of an Cardiff Oncology (CRDF) share is $4.75.
What's the market cap of Cardiff Oncology?
The current market cap of Cardiff Oncology is 316M.
Should I buy or sell CRDF?
Cardiff Oncology shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Cardiff Oncology is better viewed as a hold or accumulate position while waiting for further developments.
Is Cardiff Oncology a good investment?
The current analysis of Cardiff Oncology's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Cardiff Oncology's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Cardiff Oncology (CRDF) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Cardiff Oncology stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Cardiff Oncology (CRDF) that investors often compare it to?
Cardiff Oncology (CRDF) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Cardiff Oncology's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Cardiff Oncology's stock price to be around $4.91 in 2026. Starting from the current price of $4.75, this represents a 3.3% change in price, indicating a neutral outlook for the stock.
How to buy Cardiff Oncology (CRDF) Stock?
Cardiff Oncology stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Cardiff Oncology shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.